What are you looking for?
Increasing the dosing frequency of 0.01% atropine from once nightly to twice daily was associated with slower axial length growth over 3 months in children with myopia that had continued to progress despite initial treatment, according to a study. The analysis included 37 children aged 7 to 12 years whose axial length had increased by... ...
The U.S. Food and Drug Administration authorization of Essilor Stellest was associated with a sharp increase in U.S. online search activity related...
Children with myopia who switched to a different type of myopia-control spectacle experienced a temporary slowing of myopia progression, according to a...
Low-dose atropine did not significantly slow myopia progression in children with inherited retinal diseases (IRDs) after accounting for age-related changes, according to...
Increasing the dosing frequency of 0.01% atropine from once nightly to twice daily was associated with slower axial length growth over 3 months in children with myopia that had continued...
The U.S. Food and Drug Administration authorization of Essilor Stellest was associated with a sharp increase in U.S. online search activity related to pediatric myopia-control spectacle lenses, according to an... ...
Children with myopia who switched to a different type of myopia-control spectacle experienced a temporary slowing of myopia progression, according to a study. The retrospective matched-cohort study 1,012 children and...
Low-dose atropine did not significantly slow myopia progression in children with inherited retinal diseases (IRDs) after accounting for age-related changes, according to a study. Researchers analyzed 262 refractive examinations from...
Eva Kim, MD, of ICON Eyecare, spoke with Ophthalmology 360 at the 2026 ASCRS Annual Meeting about the ability to now use implantable collamer lenses (IOLs) in patients aged up...
Low-dose atropine (0.01%) slows myopia progression in children, with varying levels of effectiveness across different ethnic groups, according to a study. The analysis included 25 randomized controlled trials involving 4,374...
New subgroup analyses from the Phase 3 STAR trial presented at the 51st Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus show that SYD-101 0.01%, a low-dose...
Adult patients with myopia generally have positive attitudes toward refractive surgery, but their knowledge and postoperative care practices are limited, and greater knowledge is associated with better attitudes and behaviors....